NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|442621344|ref|NP_651527|]
View 

neprilysin 5, isoform E [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
151-700 1.08e-94

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 306.60  E-value: 1.08e-94
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 151 DPCEDFYQFTCGRWANEHPRPDSVTSNDWFRERQAHIMRVVREFLRSNITK-SEPEAVGKAKTMYRACMDTKLLDKRDLE 229
Cdd:cd08662    2 DPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSaADSSAEQKAKDFYKSCMDEEAIEKLGLK 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 230 PLINYLLRFGlpvlpsalnltlgsgskyatEAANVKYNWLQSIVSIKQHLTMDLIIGFDVFPDPFNRTINRIALGTPET- 308
Cdd:cd08662   82 PLKPLLDKIG--------------------GLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLg 141
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 309 DSAFPFNNDDSHKMLRKihrktifmqnsddeddseddreseeeeaakqtstgmtAYLHYVRKVIEKYllyvdpNVNQEEA 388
Cdd:cd08662  142 LPDRDYYLDEENAEIRE-------------------------------------AYKKYIAKLLELL------GADEEEA 178
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 389 TlgitelvkqgvRVARKVHEFKEEAENMTKPSKNPADDIvyITLQDLQNQTDKNIAPKtLPiWVRYMELILKGTRHAGNI 468
Cdd:cd08662  179 E-----------KLAEDVLAFETELAKISLSSEELRDPE--KTYNPLTLAELQKLAPS-ID-WKAYLKALGPPADDPDKV 243
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 469 QMTQnltiitsqadITYLQNIVEYLDDTPASHIESYLFLSTIEELVLHTSSSMRLLHSEYMRVAIGTEGSTPRSLYCANG 548
Cdd:cd08662  244 IVSQ----------PEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPEPRWKRCVEL 313
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 549 VNSLLGMAVSYVLADADFTKEKLPKVERMLSDIRRSFDRLVKSTSWMDAATKRKTIQKSAEMKSFIGFPPWLRNASVLNA 628
Cdd:cd08662  314 VNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRDYSALDI 393
                        490       500       510       520       530       540       550
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 442621344 629 YYEGAEVNaSTHLENLMDFVHWQMMDKLNEMDKP-EPIGWATSPSNVNAFHTFQSNAITVPIAILQYPFYDLG 700
Cdd:cd08662  394 YYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPvDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPD 465
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
151-700 1.08e-94

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 306.60  E-value: 1.08e-94
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 151 DPCEDFYQFTCGRWANEHPRPDSVTSNDWFRERQAHIMRVVREFLRSNITK-SEPEAVGKAKTMYRACMDTKLLDKRDLE 229
Cdd:cd08662    2 DPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSaADSSAEQKAKDFYKSCMDEEAIEKLGLK 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 230 PLINYLLRFGlpvlpsalnltlgsgskyatEAANVKYNWLQSIVSIKQHLTMDLIIGFDVFPDPFNRTINRIALGTPET- 308
Cdd:cd08662   82 PLKPLLDKIG--------------------GLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLg 141
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 309 DSAFPFNNDDSHKMLRKihrktifmqnsddeddseddreseeeeaakqtstgmtAYLHYVRKVIEKYllyvdpNVNQEEA 388
Cdd:cd08662  142 LPDRDYYLDEENAEIRE-------------------------------------AYKKYIAKLLELL------GADEEEA 178
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 389 TlgitelvkqgvRVARKVHEFKEEAENMTKPSKNPADDIvyITLQDLQNQTDKNIAPKtLPiWVRYMELILKGTRHAGNI 468
Cdd:cd08662  179 E-----------KLAEDVLAFETELAKISLSSEELRDPE--KTYNPLTLAELQKLAPS-ID-WKAYLKALGPPADDPDKV 243
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 469 QMTQnltiitsqadITYLQNIVEYLDDTPASHIESYLFLSTIEELVLHTSSSMRLLHSEYMRVAIGTEGSTPRSLYCANG 548
Cdd:cd08662  244 IVSQ----------PEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPEPRWKRCVEL 313
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 549 VNSLLGMAVSYVLADADFTKEKLPKVERMLSDIRRSFDRLVKSTSWMDAATKRKTIQKSAEMKSFIGFPPWLRNASVLNA 628
Cdd:cd08662  314 VNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRDYSALDI 393
                        490       500       510       520       530       540       550
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 442621344 629 YYEGAEVNaSTHLENLMDFVHWQMMDKLNEMDKP-EPIGWATSPSNVNAFHTFQSNAITVPIAILQYPFYDLG 700
Cdd:cd08662  394 YYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPvDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPD 465
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
152-617 4.71e-73

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 241.43  E-value: 4.71e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  152 PCEDFYQFTCGRWANEHPRPDSVTSNDWFRERQAHIMRVVREFLRSNIT-KSEPEAVGKAKTMYRACMDTKLLDKRDLEP 230
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAAsESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  231 LINYLLRFGLPVLPSAlnltlgsgskyateaanvKYNWLQSIVSIkQHLTMDLIIGFDVFPDPFNRTINRIALGTPET-- 308
Cdd:pfam05649  81 LKPLLDEIGGPLANKD------------------KFDLLETLAKL-RRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLgl 141
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  309 -DSAFPFNNDDSHKmlRKIhrktifmqnsddeddseddreseeeeaakqtstgMTAYLHYVRKVIEkylLYVDPNVNQEE 387
Cdd:pfam05649 142 pDRDYYLKDRDEKS--AEI----------------------------------REAYKAYIAKLLT---LLGASEEAAAL 182
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  388 ATlgitELVKQGVRVArKVHEFKEEAENMTKpSKNPaddivyITLQDLQNQTdKNIApktlpiWVRYMELILkgtrhagn 467
Cdd:pfam05649 183 AE----EVLAFETKLA-KASLSREERRDPEK-TYNP------MTLAELQKLA-PGID------WKAYLNAAG-------- 235
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  468 IQMTQNLTIITSQADitYLQNIVEYLDDTPASHIESYLFLSTIEELVLHTSSSMRLLHSEYMRVAIGTEgSTPRSLYCAN 547
Cdd:pfam05649 236 LPDVPSDEVIVSQPE--YLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSGTK-QRPRWKRCVS 312
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  548 GVNSLLGMAVSYVLADADFTKEKLPKVERMLSDIRRSFDRLVKSTSWMDAATKRKTIQKSAEMKSFIGFP 617
Cdd:pfam05649 313 LVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
145-699 1.20e-31

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 131.04  E-value: 1.20e-31
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 145 AMDEQTDPCEDFYQFTCGRWANEHPRPDSVTSNDWF---RER-QAHIMRVVREFLRSNITKSEPEAvgKAKTMYRACMDT 220
Cdd:COG3590   32 NMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFnelRERnEARLRAILEEAAAAPAAAGSDEQ--KIGDLYASFMDE 109
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 221 KLLDKRDLEPLINYLlrfglpvlpsalnltlgsgskyaTEAANVK-YNWLQSIVsIKQHLT-MDLIIGFDVFPDPFNRTI 298
Cdd:COG3590  110 AAIEALGLAPLKPDL-----------------------ARIDAIKdKADLAALL-AALHRAgVGGLFGFGVDADLKNSTR 165
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 299 NrIA------LGTPETDsaFPFNNDDSHKMLRKihrktifmqnsddeddseddreseeeeaakqtstgmtAYLHYVRKVI 372
Cdd:COG3590  166 Y-IAylgqggLGLPDRD--YYLKDDEKSAEIRA-------------------------------------AYVAHVAKML 205
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 373 EkyLLYVDPNVNQEEAT--LGI-TELVKqgvrvarkVHEFKEEAENMTKpSKNPaddivyITLQDLQNQTdKNIApktlp 449
Cdd:COG3590  206 E--LAGYDEADAAAAAEavLALeTALAK--------AHWSRVELRDPEK-TYNP------MTVAELAKLA-PGFD----- 262
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 450 iWVRYMElilkgTRHAGNIQmtqnlTIITSQADitYLQNIVEYLDDTPASHIESYLFLSTIeelvlhtSSSMRLLHSE-- 527
Cdd:COG3590  263 -WDAYLK-----ALGLPAVD-----EVIVGQPS--FFKALDKLLASTPLEDWKAYLRWHLL-------DSAAPYLSKAfv 322
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 528 ------YMRVAIGTEGSTPRSLYCANGVNSLLGMAVS--YVlaDADFTKEKLPKVERMLSDIRRSFDRLVKSTSWMDAAT 599
Cdd:COG3590  323 danfdfYGKTLSGQKEQRPRWKRAVALVNGALGEALGqlYV--ERYFPPEAKARMEELVANLRAAYRERIENLDWMSPET 400
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 600 KRKTIQKSAEMKSFIGFPPWLRNasvlnayYEGAEVNASTHLENLM---DFVHWQMMDKLNE-MDKPEpigWATSPSNVN 675
Cdd:COG3590  401 KAKALEKLAAFTPKIGYPDKWRD-------YSGLEIKRDDLVGNVLrasAFEYQRELAKLGKpVDRTE---WGMTPQTVN 470
                        570       580
                 ....*....|....*....|....
gi 442621344 676 AFHTFQSNAITVPIAILQYPFYDL 699
Cdd:COG3590  471 AYYNPTMNEIVFPAAILQPPFFDP 494
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
151-700 1.08e-94

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 306.60  E-value: 1.08e-94
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 151 DPCEDFYQFTCGRWANEHPRPDSVTSNDWFRERQAHIMRVVREFLRSNITK-SEPEAVGKAKTMYRACMDTKLLDKRDLE 229
Cdd:cd08662    2 DPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSaADSSAEQKAKDFYKSCMDEEAIEKLGLK 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 230 PLINYLLRFGlpvlpsalnltlgsgskyatEAANVKYNWLQSIVSIKQHLTMDLIIGFDVFPDPFNRTINRIALGTPET- 308
Cdd:cd08662   82 PLKPLLDKIG--------------------GLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLg 141
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 309 DSAFPFNNDDSHKMLRKihrktifmqnsddeddseddreseeeeaakqtstgmtAYLHYVRKVIEKYllyvdpNVNQEEA 388
Cdd:cd08662  142 LPDRDYYLDEENAEIRE-------------------------------------AYKKYIAKLLELL------GADEEEA 178
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 389 TlgitelvkqgvRVARKVHEFKEEAENMTKPSKNPADDIvyITLQDLQNQTDKNIAPKtLPiWVRYMELILKGTRHAGNI 468
Cdd:cd08662  179 E-----------KLAEDVLAFETELAKISLSSEELRDPE--KTYNPLTLAELQKLAPS-ID-WKAYLKALGPPADDPDKV 243
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 469 QMTQnltiitsqadITYLQNIVEYLDDTPASHIESYLFLSTIEELVLHTSSSMRLLHSEYMRVAIGTEGSTPRSLYCANG 548
Cdd:cd08662  244 IVSQ----------PEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSGQKEPEPRWKRCVEL 313
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 549 VNSLLGMAVSYVLADADFTKEKLPKVERMLSDIRRSFDRLVKSTSWMDAATKRKTIQKSAEMKSFIGFPPWLRNASVLNA 628
Cdd:cd08662  314 VNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKWRDYSALDI 393
                        490       500       510       520       530       540       550
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 442621344 629 YYEGAEVNaSTHLENLMDFVHWQMMDKLNEMDKP-EPIGWATSPSNVNAFHTFQSNAITVPIAILQYPFYDLG 700
Cdd:cd08662  394 YYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPvDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPD 465
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
152-617 4.71e-73

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 241.43  E-value: 4.71e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  152 PCEDFYQFTCGRWANEHPRPDSVTSNDWFRERQAHIMRVVREFLRSNIT-KSEPEAVGKAKTMYRACMDTKLLDKRDLEP 230
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAAsESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  231 LINYLLRFGLPVLPSAlnltlgsgskyateaanvKYNWLQSIVSIkQHLTMDLIIGFDVFPDPFNRTINRIALGTPET-- 308
Cdd:pfam05649  81 LKPLLDEIGGPLANKD------------------KFDLLETLAKL-RRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLgl 141
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  309 -DSAFPFNNDDSHKmlRKIhrktifmqnsddeddseddreseeeeaakqtstgMTAYLHYVRKVIEkylLYVDPNVNQEE 387
Cdd:pfam05649 142 pDRDYYLKDRDEKS--AEI----------------------------------REAYKAYIAKLLT---LLGASEEAAAL 182
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  388 ATlgitELVKQGVRVArKVHEFKEEAENMTKpSKNPaddivyITLQDLQNQTdKNIApktlpiWVRYMELILkgtrhagn 467
Cdd:pfam05649 183 AE----EVLAFETKLA-KASLSREERRDPEK-TYNP------MTLAELQKLA-PGID------WKAYLNAAG-------- 235
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  468 IQMTQNLTIITSQADitYLQNIVEYLDDTPASHIESYLFLSTIEELVLHTSSSMRLLHSEYMRVAIGTEgSTPRSLYCAN 547
Cdd:pfam05649 236 LPDVPSDEVIVSQPE--YLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSGTK-QRPRWKRCVS 312
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344  548 GVNSLLGMAVSYVLADADFTKEKLPKVERMLSDIRRSFDRLVKSTSWMDAATKRKTIQKSAEMKSFIGFP 617
Cdd:pfam05649 313 LVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
145-699 1.20e-31

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 131.04  E-value: 1.20e-31
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 145 AMDEQTDPCEDFYQFTCGRWANEHPRPDSVTSNDWF---RER-QAHIMRVVREFLRSNITKSEPEAvgKAKTMYRACMDT 220
Cdd:COG3590   32 NMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFnelRERnEARLRAILEEAAAAPAAAGSDEQ--KIGDLYASFMDE 109
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 221 KLLDKRDLEPLINYLlrfglpvlpsalnltlgsgskyaTEAANVK-YNWLQSIVsIKQHLT-MDLIIGFDVFPDPFNRTI 298
Cdd:COG3590  110 AAIEALGLAPLKPDL-----------------------ARIDAIKdKADLAALL-AALHRAgVGGLFGFGVDADLKNSTR 165
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 299 NrIA------LGTPETDsaFPFNNDDSHKMLRKihrktifmqnsddeddseddreseeeeaakqtstgmtAYLHYVRKVI 372
Cdd:COG3590  166 Y-IAylgqggLGLPDRD--YYLKDDEKSAEIRA-------------------------------------AYVAHVAKML 205
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 373 EkyLLYVDPNVNQEEAT--LGI-TELVKqgvrvarkVHEFKEEAENMTKpSKNPaddivyITLQDLQNQTdKNIApktlp 449
Cdd:COG3590  206 E--LAGYDEADAAAAAEavLALeTALAK--------AHWSRVELRDPEK-TYNP------MTVAELAKLA-PGFD----- 262
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 450 iWVRYMElilkgTRHAGNIQmtqnlTIITSQADitYLQNIVEYLDDTPASHIESYLFLSTIeelvlhtSSSMRLLHSE-- 527
Cdd:COG3590  263 -WDAYLK-----ALGLPAVD-----EVIVGQPS--FFKALDKLLASTPLEDWKAYLRWHLL-------DSAAPYLSKAfv 322
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 528 ------YMRVAIGTEGSTPRSLYCANGVNSLLGMAVS--YVlaDADFTKEKLPKVERMLSDIRRSFDRLVKSTSWMDAAT 599
Cdd:COG3590  323 danfdfYGKTLSGQKEQRPRWKRAVALVNGALGEALGqlYV--ERYFPPEAKARMEELVANLRAAYRERIENLDWMSPET 400
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 442621344 600 KRKTIQKSAEMKSFIGFPPWLRNasvlnayYEGAEVNASTHLENLM---DFVHWQMMDKLNE-MDKPEpigWATSPSNVN 675
Cdd:COG3590  401 KAKALEKLAAFTPKIGYPDKWRD-------YSGLEIKRDDLVGNVLrasAFEYQRELAKLGKpVDRTE---WGMTPQTVN 470
                        570       580
                 ....*....|....*....|....
gi 442621344 676 AFHTFQSNAITVPIAILQYPFYDL 699
Cdd:COG3590  471 AYYNPTMNEIVFPAAILQPPFFDP 494
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH